4.7 Article

Azaphilones from an Acid Mine Extremophile Strain of a Pleurostomophora sp.

期刊

JOURNAL OF NATURAL PRODUCTS
卷 78, 期 12, 页码 2917-2923

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jnatprod.5b00519

关键词

-

资金

  1. NSF [CHE-9977213]
  2. NIH [P20GM103546, P20RR16455-04, P20RR017670, 5P30NS055022, RC2ES018742]
  3. USGS [02HQGR0121]
  4. National Institute of General Medical Sciences [P20GM10356]
  5. NIH/NCI Cancer Center [5 P30 CA008748-44]

向作者/读者索取更多资源

An extremophilic fungus identified as a Pleurostomophora sp. was isolated from the Berkeley Pit, an acid mine waste lake. When grown in liquid culture, the fungus produced berkchaetoazaphilones A-C (1, 2, and 5), the red pigment berkchaetorubramine (6), and the known compound 4-(hydroxymethyl)quinoline. These compounds were evaluated as inhibitors of matrix metalloproteinase-3, caspase-1, and proinflammatory cytokine production in induced THP-1 cells. Berkchaetoazaphilone B (2) inhibited IL-1 beta, TNF alpha, and IL-6 production in the induced inflammasome assay and was cytotoxic toward human retinoblastoma cell line Y79 (IC50 = 1.1 mu M), leukemia cell lines CCRF-CEM and SR, and the melanoma cell line LOX IMVI (IC50 = 10 mu M).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

Neerav Shukla, Romel Somwar, Roger S. Smith, Sri Ambati, Stanley Munoz, Melinda Merchant, Padraig D'Arcy, Xin Wang, Rachel Kobos, Christophe Antczak, Bhavneet Bhinder, David Shum, Constantin Radu, Guangbin Yang, Barry S. Taylor, Charlotte K. Y. Ng, Britta Weigelt, Inna Khodos, Elisa de Stanchina, Jorge S. Reis-Filho, Ouathek Ouerfelli, Stig Linder, Hakim Djaballah, Marc Ladanyi

CANCER RESEARCH (2016)

Article Microbiology

Nanomolar Inhibitors of Trypanosoma brucei RNA Triphosphatase

Paul Smith, C. Kiong Ho, Yuko Takagi, Hakim Djaballah, Stewart Shuman

Article Biochemical Research Methods

Evaluation of Compound Optical Interference in High-Content Screening

Glorymar Ibanez, Paul A. Calder, Constantin Radu, Bhavneet Bhinder, David Shum, Christophe Antczak, Hakim Djaballah

SLAS DISCOVERY (2018)

Article Biochemistry & Molecular Biology

Small-Molecule Inhibitors of SETD8 with Cellular Activity

Gil Blum, Glorymar Ibanez, Xiangjun Rao, David Shum, Constantin Radu, Hakim Djaballah, Judd C. Rice, Minkui Luo

ACS CHEMICAL BIOLOGY (2014)

Article Biochemical Research Methods

A High-Content Assay Strategy for the Identification and Profiling of ABCG2 Modulators in Live Cells

Christophe Antczak, Boyoung Wee, Constantin Radu, Bhavneet Bhinder, Eric C. Holland, Hakim Djaballah

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)

Article Multidisciplinary Sciences

ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells

Boyoung Wee, Alexander Pietras, Tatsuya Ozawa, Elena Bazzoli, Ondrej Podlaha, Christophe Antczak, Bengt Westermark, Sven Nelander, Lene Uhrbom, Karin Forsberg-Nilsson, Hakim Djaballah, Franziska Michor, Eric C. Holland

SCIENTIFIC REPORTS (2016)

Article Cell Biology

Death Induced by CD95 or CD95 Ligand Elimination

Abbas Hadji, Paolo Ceppi, Andrea E. Murmann, Sonia Brockway, Abhinandan Pattanayak, Bhavneet Bhinder, Annika Hau, Shirley De Chant, Vamsi Parimi, Piotre Kolesza, JoAnne Richards, Navdeep Chandel, Hakim Djaballah, Marcus E. Peter

CELL REPORTS (2014)

Article Cell Biology

BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors

Enrico Derenzini, Patrizia Mondello, Tatiana Erazo, Ana Portelinha, Yuxuan Liu, Mary Scallion, Zahra Asgari, John Philip, Patrick Hilden, Debora Valli, Alessandra Rossi, Hakim Djaballah, Ouathek Ouerfelli, Elisa de Stanchina, Venkatraman E. Seshan, Ronald C. Hendrickson, Anas Younes

CELL REPORTS (2018)

Article Oncology

A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma

Christina Angeles, Ana Velez, Jordan Rios, Bernadette Laxa, David Shum, Penelope D. Ruiz, Yawei Shen, Irina Ostrovnaya, Rodrigo Gularte-Merida, Benjamin A. Nacev, Mark A. Dickson, Hakim Djaballah, Tomoyo Okada, Samuel Singer

Summary: This study aims to find potential treatments for dedifferentiated liposarcoma (DDLS) by increasing the expression of C/EBP alpha. The results showed that irinotecan can induce apoptosis in DDLS cells through C/EBP alpha-dependent, p53-independent mechanisms, suggesting its therapeutic potential.

CLINICAL CANCER RESEARCH (2022)

Article Cell Biology

Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells

Fraser D. Johnson, John Ferrarone, Alvin Liu, Christina Brandstaedter, Ravi Munuganti, Dylan A. Farnsworth, Daniel Lu, Jennifer Luu, Tianna Sihota, Sophie Jansen, Amy Nagelberg, Rocky Shi, Giovanni C. Forcina, Xu Zhang, Grace S. W. Cheng, Sandra E. Spencer Miko, Georgia de Rappard-Yuswack, Poul H. Sorensen, Scott J. Dixon, Udayan Guha, Katja Becker, Hakim Djaballah, Romel Somwar, Harold Varmus, Gregg B. Morin, William W. Lockwood

Summary: Phenotype-based screening led to the identification of a compound called LCS3 that selectively impairs the growth of LUAD cells, induces oxidative stress, and inhibits the activity of disulfide reductases GSR and TXNRD1. The study also reveals that LCS3-sensitive LUAD cells are sensitive to the synergistic inhibition of glutathione and thioredoxin pathways. Furthermore, NQO1 loss is identified as a mechanism of LCS3 resistance through a genome-wide CRISPR knockout screen.

CELL REPORTS (2022)

Article Oncology

Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents

Thapi D. Rao, Mengyao Xu, Stephanie Eng, Guangli Yang, Robin Manson, Nestor Rosales, Raj Kumar, Irva E. Veillard, Qin Zhou, Alexia Iasonos, Ouathek Ouerfelli, Hakim Djaballah, David R. Spriggs, Oladapo O. Yeku

Summary: Significant progress has been made in the development of precision therapeutics for cancer, with a focus on aberrantly expressed glycoproteins. Through various screening strategies, compounds that selectively target MUC16(+) cells have been identified. These candidates demonstrate preferential inhibition of invasion in MUC16(+) cells and may have potential for further clinical development.

MOLECULAR CANCER THERAPEUTICS (2022)

Article Ophthalmology

Pharmacokinetics, Safety, and Efficacy of Intravitreal Digoxin in Preclinical Models for Retinoblastoma

Ursula Winter, Emiliano Buitrago, Hebe A. Mena, Maria Jose Del Sole, Viviana Laurent, Soledad Negrotto, Jasmine Francis, Eloisa Arana, Mariana Sgroi, Juan O. Croxatto, Hakim Djaballah, Guillermo L. Chantada, David Abramson, Paula Schaiquevich

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)

Article Biochemical Research Methods

A Multiplexed Cell-Based Assay for the Identification of Modulators of Pre-Membrane Processing as a Target against Dengue Virus

Zachary D. Stolp, Cameron A. Smurthwaite, Connor Reed, Wesley Williams, Andre Dharmawan, Hakim Djaballah, Roland Wolkowicz

JOURNAL OF BIOMOLECULAR SCREENING (2015)

Article Biochemical Research Methods

Plasmid-Based shRNA Lentiviral Particle Production for RNAi Applications

David Shum, Hakim Djaballah

JOURNAL OF BIOMOLECULAR SCREENING (2014)

暂无数据